Kabuto H, Yokoi I, Habu H, Asahara H, Mori A
Department of Neuroscience, Okayama University Medical School, Japan.
Neuroreport. 1995 Feb 15;6(3):554-6. doi: 10.1097/00001756-199502000-00036.
Nitric oxide is synthesized by nitric oxide synthase (NOS) from L-Arg, which contains a guanidino group. Arcaine is the diguanidino compound and a derivative of Arg. This study was conducted to investigate the effects of arcaine on rat brain NOS activity, using nitrite and nitrate as indicators. Arcaine inhibited NOS activity in a linear mixed manner (K1 = 18.68 microM). Almost all previously reported NOS inhibitors were synthesized by substituting the guanidino nitrogen of Arg, but the guanidino nitrogens of arcaine were not substituted. Arcaine was also reported to be a competitive antagonist of the polyamine site on the N-methyl-D-aspartic acid (NMDA) receptor. Arcaine appears to be an excellent drug to investigate not only the chemical nature of NOS but also the functional and structural relationship between NOS and NMDA receptors.
一氧化氮由一氧化氮合酶(NOS)从含有胍基的L-精氨酸合成。鹅肌肽是双胍基化合物,也是精氨酸的衍生物。本研究以亚硝酸盐和硝酸盐为指标,旨在探讨鹅肌肽对大鼠脑NOS活性的影响。鹅肌肽以线性混合方式抑制NOS活性(K1 = 18.68微摩尔)。几乎所有先前报道的NOS抑制剂都是通过取代精氨酸的胍基氮合成的,但鹅肌肽的胍基氮并未被取代。据报道,鹅肌肽也是N-甲基-D-天冬氨酸(NMDA)受体上多胺位点的竞争性拮抗剂。鹅肌肽似乎是一种不仅能研究NOS化学性质,还能研究NOS与NMDA受体之间功能和结构关系的优良药物。